This vaccine can induce a functional anti-xCT antibody response, reproducing the effect of ROS accumulation and GSH decrease in breast cancer cells that have previously been observed with xCT antibodies induced by DNA vaccination. This evidence concerns the gene SLC7A11 and breast carcinoma.